Jonathan Bauman

2.5k total citations · 1 hit paper
28 papers, 1.6k citations indexed

About

Jonathan Bauman is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Jonathan Bauman has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Jonathan Bauman's work include Pharmacogenetics and Drug Metabolism (17 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Jonathan Bauman is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Jonathan Bauman collaborates with scholars based in United States, Denmark and Israel. Jonathan Bauman's co-authors include Amit S. Kalgutkar, David A. Price, Daniel P. Walker, Michael D. Aleo, Thomas A. Baillie, Antonia F. Stepan, Theunis C. Goosen, R. Scott Obach, J. Andrew Williams and Robert L. Walsky and has published in prestigious journals such as Journal of Medicinal Chemistry, Nature Chemical Biology and Chemical Research in Toxicology.

In The Last Decade

Jonathan Bauman

28 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States

2011 494 citations Daniel P. Walker, Jonathan Bauman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Bauman United States	17	709	650	325	264	263	28	1.6k
Charles J. Rotter United States	17	474 0.7×	367 0.6×	613 1.9×	219 0.8×	137 0.5×	25	1.3k
Eszter Hazai Hungary	23	801 1.1×	283 0.4×	442 1.4×	286 1.1×	307 1.2×	46	1.8k
B. Michael Silber United States	21	691 1.0×	650 1.0×	454 1.4×	229 0.9×	185 0.7×	49	2.0k
Gian Camenisch Switzerland	26	871 1.2×	525 0.8×	915 2.8×	440 1.7×	318 1.2×	56	2.5k
Zhengyin Yan United States	26	803 1.1×	587 0.9×	369 1.1×	278 1.1×	125 0.5×	59	1.8k
Suresh K. Balani United States	26	772 1.1×	639 1.0×	755 2.3×	199 0.8×	370 1.4×	69	2.6k
Jonathan Cheong United States	13	444 0.6×	177 0.3×	412 1.3×	209 0.8×	140 0.5×	30	1.3k
S. Cyrus Khojasteh United States	24	627 0.9×	617 0.9×	609 1.9×	191 0.7×	154 0.6×	94	1.6k
А. А. Гилеп Belarus	23	680 1.0×	743 1.1×	221 0.7×	191 0.7×	66 0.3×	110	1.7k
Jan L. Wahlstrom United States	22	348 0.5×	729 1.1×	354 1.1×	187 0.7×	112 0.4×	47	1.3k

Countries citing papers authored by Jonathan Bauman

Since Specialization

Citations

This map shows the geographic impact of Jonathan Bauman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Bauman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Bauman more than expected).

Fields of papers citing papers by Jonathan Bauman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Bauman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Bauman. The network helps show where Jonathan Bauman may publish in the future.

Co-authorship network of co-authors of Jonathan Bauman

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Bauman. A scholar is included among the top collaborators of Jonathan Bauman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Bauman. Jonathan Bauman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bauman, Jonathan, et al.. (2024). Heat-Related Illnesses. Emergency Medicine Clinics of North America. 42(3). 485–492. 4 indexed citations

Bauman, Jonathan, Angela C. Doran, Brian Hee, et al.. (2024). The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans. Drug Metabolism and Disposition. 52(10). 1124–1136. 7 indexed citations

Bauman, Jonathan, Angela C. Doran, Amanda King‐Ahmad, et al.. (2022). The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in Humans. Drug Metabolism and Disposition. 50(8). 1106–1118. 24 indexed citations

Piotrowski, David W., Kentaro Futatsugi, M. F. Sammons, et al.. (2018). David W. Piotrowski, * Kentaro Futatsugi, Agustin Casimiro-Garcia, Liuqing Wei, Matthew F. Sammons, Michael Herr, Wenhua Jiao, Sophie Y. Lavergne, Steven B. Co ff ey, Stephen W. Wright, Kun Song, Paula M. Loria, Mary Ellen Banker, Donna N. Petersen, and J. Journal of Medicinal Chemistry. 3 indexed citations

Walker, Gregory S., Jonathan Bauman, Tim F. Ryder, et al.. (2014). Biosynthesis of Drug Metabolites and Quantitation Using NMR Spectroscopy for Use in Pharmacologic and Drug Metabolism Studies. Drug Metabolism and Disposition. 42(10). 1627–1639. 41 indexed citations

Walsky, Robert L., Jonathan Bauman, Kimberly Lapham, et al.. (2012). Optimized Assays for Human UDP-Glucuronosyltransferase (UGT) Activities: Altered Alamethicin Concentration and Utility to Screen for UGT Inhibitors. Drug Metabolism and Disposition. 40(5). 1051–1065. 122 indexed citations

Rezai, Taha, Vladimir Gelev, Rushia Turner, et al.. (2011). On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds. Nature Chemical Biology. 7(11). 810–817. 304 indexed citations

Eng, Heather, Mark Niosi, Thomas S. McDonald, et al.. (2010). Utility of the carboxylesterase inhibitorbis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor. Xenobiotica. 40(6). 369–380. 53 indexed citations

Bauman, Jonathan, David A. Price, Paul S. Humphries, et al.. (2010). Metabolism-Guided Design of Short-Acting Calcium-Sensing Receptor Antagonists. ACS Medicinal Chemistry Letters. 1(5). 219–223. 10 indexed citations

10.

Sun, Hao, Raman Sharma, Jonathan Bauman, et al.. (2009). Differences in CYP3A4 catalyzed bioactivation of 5-aminooxindole and 5-aminobenzsultam scaffolds in proline-rich tyrosine kinase 2 (PYK2) inhibitors: Retrospective analysis by CYP3A4 molecular docking, quantum chemical calculations and glutathione adduct detection using linear ion trap/orbitrap mass spectrometry. Bioorganic & Medicinal Chemistry Letters. 19(12). 3177–3182. 6 indexed citations

11.

Bauman, Jonathan, et al.. (2009). Utility of MetaSite in Improving Metabolic Stability of the Neutral Indomethacin Amide Derivative and Selective Cyclooxygenase-2 Inhibitor 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-N-phenethyl-acetamide. Drug Metabolism and Disposition. 37(5). 999–1008. 15 indexed citations

12.

Kalgutkar, Amit S., et al.. (2009). Biochemical basis for differences in metabolism-dependent genotoxicity by two diazinylpiperazine-based 5-HT2C receptor agonists. Bioorganic & Medicinal Chemistry Letters. 19(6). 1559–1563. 16 indexed citations

13.

Bauman, Jonathan, Kosea S. Frederick, Robert L. Walsky, et al.. (2008). Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug. Drug Metabolism and Disposition. 36(6). 1016–1029. 60 indexed citations

14.

Kalgutkar, Amit S., Gwendolyn D. Fate, Mary T. Didiuk, & Jonathan Bauman. (2008). Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?. Expert Review of Clinical Pharmacology. 1(4). 515–531. 19 indexed citations

15.

Peterkin, Vincent, Jonathan Bauman, Theunis C. Goosen, et al.. (2007). Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes. British Journal of Clinical Pharmacology. 64(4). 458–468. 46 indexed citations

16.

Goosen, Theunis C., Jonathan Bauman, John A. Davis, et al.. (2007). Atorvastatin Glucuronidation Is Minimally and Nonselectively Inhibited by the Fibrates Gemfibrozil, Fenofibrate, and Fenofibric Acid. Drug Metabolism and Disposition. 35(8). 1315–1324. 45 indexed citations

17.

Bauman, Jonathan, Theunis C. Goosen, Meera Tugnait, et al.. (2005). UDP-GLUCURONOSYLTRANSFERASE 2B7 IS THE MAJOR ENZYME RESPONSIBLE FOR GEMCABENE GLUCURONIDATION IN HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition. 33(9). 1349–1354. 16 indexed citations

18.

Williams, J. Andrew, Jonathan Bauman, Hongliang Cai, et al.. (2005). In vitro ADME phenotyping in drug discovery: current challenges and future solutions.. PubMed. 8(1). 78–88. 12 indexed citations

19.

Williams, John A., Susan Hurst, Jonathan Bauman, et al.. (2003). Reaction Phenotyping in Drug Discovery: Moving Forward with Confidence?. Current Drug Metabolism. 4(6). 527–534. 39 indexed citations

20.

Sahi, Jasminder, et al.. (2002). The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs. Drug Metabolism and Disposition. 30(2). 135–140. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact